Human pheromones, peanut butter, and neurodegenerative disease

October 11, 2013 | James Kohl

Peanut butter sniff test confirms Alzheimer’s University of Florida: Original Study Posted by editor@futurity.org on

Excerpt: ‘The ability to smell is associated with the first cranial nerve and is often one of the first things affected in cognitive decline. Because peanut butter is a “pure odorant,” it is only detected by the olfactory nerve and is easy to access.”

My comment: Results from the peanut butter sniff test may put my antagonist, Dr. Richard L. Doty, out of business. He markets smell tests that require too much time and extensive interpretation-based costs. Medical practitioners must refuse — based on time constraints, and costs — to use them in their practice.

Dr. Doty also has stated that mammalian pheromones do not exist. That includes human pheromones, which was the point he most wanted to make. (I know this from talking to him at the same conferences Jennifer Stamps and I attended.) More than a decade ago he was telling me and others that he was going to write a book about human pheromones.

Jennifer’s personal experience-dependent de novo creation of olfactory receptor genes, which increased her sensitivity to the chemicals in my product, exemplifies the fact that human pheromones and food odors, such as the odor of peanut butter, act via molecular mechanisms conserved in species from microbes to man. The fact that molecular mechanisms of the pathways involved are conserved refutes Doty’s academically irresponsible claim that mammalian pheromones don’t exist, which he says is because we are not like insects.

My model shows that conserved molecular mechanisms clearly link insects and microbes to a human population in what is now central China via the change in a single base pair of DNA, the smallest demonstrable change currently known. You’ll be reading more about this during the next decade, and hopefully Jennifer’s additional works will continue to link across-species examples of biologically-based cause and effect to potential treatment options that include what is known about biological facts. Those facts exclude virtually everything Doty wrote about in his book “The Great Pheromone Myth,” but include everything Bob Francoeur and I wrote about in “The Scent of Eros: Mysteries of Odor in Human Sexuality.”

The research reported by Stamps et al., in A brief olfactory test for Alzheimer’s disease, can now be linked to a patent, which suggests that human pheromones may be an effective treatment for neurodegenerative diseases: Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis. The alternative, of course, is to have someone stick a needle into your brain to inject the stem cells, which makes the work by Jennifer Stamps et al., even more important to people who have a fear of needles but do not have a fear of pheromones.

Comments

comments

James Vaughn Kohl

James Vaughn Kohl

James Vaughn Kohl was the first to accurately conceptualize human pheromones, and began presenting his findings to the scientific community in 1992. He continues to present to, and publish for, diverse scientific and lay audiences, while constantly monitoring the scientific presses for new information that is relevant to the development of his initial and ongoing conceptualization of human pheromones.